| ID | Title | Session | Presenting author | ||
| 01.1 | The future of review production for Cochrane | Session 1 | Jessica Thomas | Sessions Day 1 | |
| 01.2 | Personally tailored, multilingual, up-to-date evidence-based summaries of effects of care, when and where you want it: an EU bid | Session 1 | Marianna Purgato | ||
| 01.3 | Piloting living systematic reviews in traumatic brain injury | Session 1 | Anneliese Synnot | ||
| 01.4 | linkedPICO project: how to make different tools and platforms in the medical knowledge ecosystem talk past their silos | Session 1 | Linn Brandt | ||
| 02.1 | Enhancing the acceptance and implementation of summary of findings tables in Cochrane Reviews: user testing study | Session 2 | Alonso Carrasco-Labra | ||
| 02.2 | Enhancing the acceptance and implementation of summary of findings tables in Cochrane Reviews: two non-inferiority randomized controlled trials | Session 2 | Alonso Carrasco-Labra | ||
| 02.3 | An approach to evaluate the quality of evidence from a network meta-analysis | Session 2 | Cinzia Del Giovane | ||
| 02.4 | Rating the quality of the evidence for the studies that evaluate the importance of the outcomes of interest | Session 2 | Pablo Alonso | ||
| 03.1 | Impact of missing outcome data for participants in trials included in five Cochrane Reviews: an imputation study | Session 3 | Lara Kahale | ||
| 03.2 | Interpreting trial results following use of different intention-to-treat approaches for preventing attrition bias: a meta-epidemiological study | Session 3 | Robin Christensen | ||
| 03.3 | The moral dimensions of meta-analysis: a grounded theory of the meta-analytic process | Session 3 | Ian Shrier | ||
| 03.4 | Prediction study risk of bias assessment tool (PROBAST) | Session 3 | Robert Wolff | ||
| 04.1 | Global burden of skin disease in 2010 and systematic reviews and protocols in Cochrane Database of Systematic Reviews | Session 4 | Robert Dellavalle | ||
| 04.2 | Systematic reviews addressing identified policy priorities in Eastern Mediterranean countries: a situational analysis | Session 4 | Elie Akl | ||
| 04.3 | Setting research priorities with multiple professions and service users | Session 4 | Sandy Oliver | ||
| 04.4 | Update of the Cochrane Review of interventions for preventing obesity in children: priority setting | Session 4 | Elizabeth Waters | ||
| 05.1 | Introducing LATITUDES: a library of assessment tools and instruments used to assess data validity in evidence syntheses | Session 5 | Penny Whiting | ||
| 05.2 | Methodological considerations for assessing risk of bias in non-randomized studies | Session 5 | Jonathan Sterne | ||
| 05.3 | A new tool to assess risk of bias in non-randomized studies | Session 5 | Jonathan Sterne | ||
| 05.4 | ROBIS: a new tool to assess the risk of bias in a systematic review | Session 5 | Penny Whiting | ||
| 06.1 | Rayyan: a systematic reviews web app for exploring and filtering searches for eligible studies for Cochrane Reviews | Session 6 | Zbys Fedorowicz | Sessions Day 2 | |
| 06.2 | Using text mining technologies can reduce screening workload in systematic reviews in practice as well as in theory | Session 6 | James Thomas | ||
| 06.3 | Automatic information retrieval: citation tracking, deduplication and full-text fetching | Session 6 | Guy Tsafnat | ||
| 06.4 | Anywhere Cochrane Reviews: responsive web design, the 'connected article' and Cochrane evidence | Session 6 | Gavin Stewart | ||
| 07.1 | Do we have Cochrane Reviews for the more relevant questions? Are they the best choice? Analysis of clinical questions in internal medicine | Session 7 | Gabriel Rada | ||
| 07.2 | Evaluating the impact of Cochrane Reviews | Session 7 | Daksha Trivedi | ||
| 07.3 | Cochrane Reviews: the linchpins of knowledge translation and impact | Session 7 | Philippa Middleton | ||
| 07.4 | ‘Buying’ into Cochrane: how do Fields measure success? | Session 7 | Craig Lockwood | ||
| 08.1 | Policy 'buddies': policymaker and researcher engagement for evidence-informed policy | Session 8 | Taryn Young | ||
| 08.2 | Seizing opportunities: engaging policy makers in evidence informed discussions, planning and policy making | Session 8 | Krishna Aryal | ||
| 08.3 | Linking diagnostic test accuracy reviews to global priorities: case study of TB | Session 8 | Marty Richardson | ||
| 08.4 | Social values underlying priority setting | Session 8 | David Gough | ||
| 09.1 | Completeness of outcomes description reported in low-back pain rehabilitation interventions: a survey of trials included in Cochrane Reviews | Session 9 | Silvia Gianola | ||
| 09.2 | Survey of outcomes in Cochrane Reviews: support for ‘core outcome set’ (COS) development | Session 9 | Valerie Smith | ||
| 09.3 | Progressing towards core outcomes in gestational diabetes clinical trials and Cochrane Reviews | Session 9 | Emily Bain | ||
| 09.4 | Do Cochrane Reviews measure enough of what patients want? A collaborative study of Cochrane Reviews on HIV/AIDS | Session 9 | Ian Saldanha | ||
| 10.1 | Exploring treatment by covariate interactions in Cochrane Reviews: recent practice | Session 10 | Sarah Donegan | ||
| 10.2 | Reliability of estimating odds ratios of response and the corresponding standard errors from continuous rating scale scores for meta-analysis: a case study in trials on depression treatment | Session 10 | Ramona Meister | ||
| 10.3 | Multiple imputation of systematically missing predictors in an individual participant data meta-analysis: a generalized approach using MICE | Session 10 | Thomas Debray | ||
| 10.4 | Testing for intervention effects in the random-effects model: a comparison of different statistical methods | Session 10 | Joseph Beyene | ||
| 11.1 | Facilitating research on research using SWAR (studies within a review) and SWAT (studies within a trial) | Session 11 | Mike Clarke | Sessions Day 3 | |
| 11.2 | The EMBASE project: an analysis of highlighted words and phrases | Session 11 | Anna Noel-Storr | ||
| 11.3 | Citation screening in systematic reviews: two approaches, two authors and time taken (SWAR-1 (Study Within A Review 1)) | Session 11 | Mike Clarke | ||
| 12.1 | From summary to synthesis: a review of statistical synthesis and presentation methods used in complex reviews | Session 12 | Joanne McKenzie | ||
| 12.2 | Can Qualitative Comparative Analysis help us to identify important components of complex interventions? | Session 12 | James Thomas | ||
| 12.3 | Characteristics of realist synthesis reviews: a systematic mapping review of realist reviews | Session 12 | Rigmor Berg | ||
| 12.4 | Assessing how much confidence to place in findings from qualitative evidence syntheses: a new version of the CERQual tool | Session 12 | Jane Noyes | ||
| 13.1 | Do Cochrane summaries help student midwives understand the findings of Cochrane reviews: the BRIEF randomised trial | Session 13 | Fiona Alderdice | ||
| 13.2 | SWAR 2: How much do you need? Can readers get the key messages from summaries of Cochrane Reviews, without reading the full review? | Session 13 | Lisa Maguire | ||
| 13.3 | Online filter bubbles and confirmation bias in health care: narrative of a vaccine skeptic | Session 13 | Giordano Pérez Gaxiola | ||
| 13.4 | Implementing multilayered presentation formats in a new generation of trustworthy clinical practice guidelines | Session 13 | Linn Brandt | ||
| 14.1 | A systematic review on the impact of studies that are not fully published on results of meta-analyses | Session 14 | Joerg Meerpohl | ||
| 14.2 | An empirical investigation of the potential impact of selective inclusion of results in systematic reviews of interventions | Session 14 | Matthew Page | ||
| 14.3 | Massive production of meta-analyses of antidepressants with industry authorship or industry-related conflicts | Session 14 | Shanil Ebrahim | ||
| 14.4 | Publication bias tests for survival data: a simulation study | Session 14 | Thomas Debray | ||
| 15.1 | Relationship between global burden of disease and quantity of published randomized controlled trials | Session 15 | Connor Emdin | ||
| 15.2 | The use of systematic reviews in the design of randomized controlled trials of acupuncture: a systematic review | Session 15 | Kun Hyung Kim | ||
| 15.3 | Quality of descriptions of rehabilitation interventions in low back pain: a review of published randomized controlled trials | Session 15 | Silvia Gianola | ||
| 15.4 | Reporting of randomized clinical trials discontinued due to poor recruitment: a literature review | Session 15 | Erik VonElm | ||
| 16.1 | A new approach to update Cochrane Reviews focusing on the 'Summary of findings' (SoFs) | Session 16 | Karla Soares-Weiser | ||
| 16.2 | Updating for quality: reflections on our editorial policy | Session 16 | Paul Garner | ||
| 16.3 | Five evidence ‘game changers’ in 2013 and what this means for Cochrane Reviews | Session 16 | Brian Alper | ||
| 17.1 | The importance of process evaluation: a tale of two reviews | Session 17 | Elizabeth Kristjansson | Sessions Day 4 | |
| 17.2 | Intervention Component Analysis (ICA): enhancing the “implementability” of review findings on complex interventions | Session 17 | Katy Sutcliffe | ||
| 17.3 | Using evidence syntheses: views and experiences of public health decision makers and review authors in the United Kingdom | Session 17 | Daniel Francis | ||
| 17.4 | The Cochrane Review moving beyond RCTs: philosophical notions of causality and its implications | Session 17 | Jackie Chandler | ||
| 18.1 | The quality of evidence is a key determinant of strength of recommendations | Session 18 | Benjamin Djulbegovic | ||
| 18.2 | Use of information from summary of findings tables in the clinical practice guidelines development: a pilot study in Colombia | Session 18 | María Ximena Rojas | ||
| 18.3 | Exploring why WHO guideline panels are frequently making strong recommendations based on low study quality (high uncertainty) | Session 18 | Gordon Guyatt | ||
| 18.4 | Understanding the determinants WHO guideline panels consider in making strong recommendations in the face of low or very low confidence (study quality) in effect estimates | Session 18 | Gordon Guyatt | ||
| 19.1 | Multiple systematic reviews published on the same topic area: an analysis of systematic reviews that overlap in content | Session 19 | Michelle Foisy | ||
| 19.2 | Conducting overviews of reviews: lessons learned since 2006 | Session 19 | Michelle Foisy | ||
| 19.3 | Risk of bias: are judgements consistent between reviews? | Session 19 | Sarah Lensen | ||
| 19.4 | Data sharing: is it getting easier to access individual participant data? Experiences from the Cochrane Epilepsy Group | Session 19 | Sarah Nolan | ||
| 20.1 | Strengthening capacity for producing systematic reviews in low and middle income countries | Session 20 | Sandy Oliver | ||
| 20.2 | Primer in systematic reviews and research synthesis: helping people to find, appraise, interpret and use systematic reviews in Africa | Session 20 | Taryn Young | ||
| 20.3 | GAME-IT: explore peoples choices and facilitate teaching by turning evidence processing into a game | Session 20 | Linn Brandt | ||
| 20.4 | Engaging with younger generations through Students 4 Best Evidence: the follow-up | Session 20 | Holly Millward | ||
| 21.1 | Registration of randomized controlled trials published in PubMed indexed journals: a cross-sectional analysis | Session 21 | Ayodele Odutayo | ||
| 21.3 | Editorial policies and trial registration status for published trials in Indian medical journals | Session 21 | Soumyadeep Bhaumik | ||
| 21.3 | Changing patterns of clinical trial activity in Australia: 2005-2013 | Session 21 | Lisa Askie | ||
| 21.4 | Transparent reporting of a multi-variable prediction model for individual prognosis or diagnosis: the TRIPOD statement | Session 21 | Karel Moons | ||
| 22.1 | Trial data available in FDA and EMA reports: a cross-sectional study | Session 22 | Jeppe Schroll | ||
| 22.2 | How can we accurately diagnose schizophrenia? Challenges in performing Cochrane diagnostic test accuracy reviews in schizophrenia | Session 22 | Karla Soares-Weiser | ||
| 22.4 | Open access and Cochrane Reviews | Session 22 | Harriet MacLehose | ||